Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted?
An accumulation of experimental data suggests that N-methyl-D-aspartate (NMDA) receptor antagonists will prevent ischemic neuronal injury following transient global ischemia and reduce infarct volumes following focal ischemic insults. The excitotoxic hypothesis states that the excitatory amino acid...
Main Author: | |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1990
|